<DOC>
	<DOCNO>NCT00015288</DOCNO>
	<brief_summary>The purpose study examine pharmacokinetics dose proportionality sublingual tablet contain vary dos buprenorphine naloxone .</brief_summary>
	<brief_title>Buprenorphine Naloxone Combination Study - 10</brief_title>
	<detailed_description>The objective study examine pharmacokinetics dose proportionality sublingual tablet contain vary dos buprenorphine naloxone .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<criteria>Male/Female age 21 45 . Within 15 % ideal body weight . No oral pathology would interfere sublingual absorption medication . Experienced use opiates dependent . LFT 's exceed 3x 's normal . History seizure . Opiate dependent .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 1998</verification_date>
</DOC>